These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Bedtime ingestion of hypertension medications reduces the risk of new-onset type 2 diabetes: a randomised controlled trial. Hermida RC; Ayala DE; Mojón A; Fernández JR Diabetologia; 2016 Feb; 59(2):255-65. PubMed ID: 26399404 [TBL] [Abstract][Full Text] [Related]
5. Cardiovascular risk of essential hypertension: influence of class, number, and treatment-time regimen of hypertension medications. Hermida RC; Ayala DE; Mojón A; Fernández JR Chronobiol Int; 2013 Mar; 30(1-2):315-27. PubMed ID: 23181712 [TBL] [Abstract][Full Text] [Related]
6. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Hermida RC; Ayala DE; Mojón A; Fernández JR Chronobiol Int; 2010 Sep; 27(8):1629-51. PubMed ID: 20854139 [TBL] [Abstract][Full Text] [Related]
7. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction. Hermida RC; Ayala DE; Fernández JR; Mojón A Chronobiol Int; 2013 Mar; 30(1-2):68-86. PubMed ID: 23181592 [TBL] [Abstract][Full Text] [Related]
8. Chronotherapy with conventional blood pressure medications improves management of hypertension and reduces cardiovascular and stroke risks. Hermida RC; Ayala DE; Smolensky MH; Fernández JR; Mojón A; Portaluppi F Hypertens Res; 2016 May; 39(5):277-92. PubMed ID: 26657008 [TBL] [Abstract][Full Text] [Related]
9. Influence of time of day of blood pressure-lowering treatment on cardiovascular risk in hypertensive patients with type 2 diabetes. Hermida RC; Ayala DE; Mojón A; Fernández JR Diabetes Care; 2011 Jun; 34(6):1270-6. PubMed ID: 21617110 [TBL] [Abstract][Full Text] [Related]
10. Risk of incident chronic kidney disease is better reduced by bedtime than upon-awakening ingestion of hypertension medications. Hermida RC; Ayala DE; Mojón A; Fernández JR Hypertens Res; 2018 May; 41(5):342-353. PubMed ID: 29531290 [TBL] [Abstract][Full Text] [Related]
11. Administration-time-dependent effects of hypertension treatment on ambulatory blood pressure in patients with chronic kidney disease. Crespo JJ; Piñeiro L; Otero A; Castiñeira C; Ríos MT; Regueiro A; Mojón A; Lorenzo S; Ayala DE; Hermida RC; Chronobiol Int; 2013 Mar; 30(1-2):159-75. PubMed ID: 23098134 [TBL] [Abstract][Full Text] [Related]
12. Effects of time-of-day of hypertension treatment on ambulatory blood pressure and clinical characteristics of patients with type 2 diabetes. Moyá A; Crespo JJ; Ayala DE; Ríos MT; Pousa L; Callejas PA; Salgado JL; Mojón A; Fernández JR; Hermida RC; Chronobiol Int; 2013 Mar; 30(1-2):116-31. PubMed ID: 23181613 [TBL] [Abstract][Full Text] [Related]
13. Role of time-of-day of hypertension treatment on the J-shaped relationship between blood pressure and cardiovascular risk. Hermida RC; Ayala DE; Mojón A; Fernández JR Chronobiol Int; 2013 Mar; 30(1-2):328-39. PubMed ID: 23181738 [TBL] [Abstract][Full Text] [Related]
14. Chronotherapy with valsartan/amlodipine fixed combination: improved blood pressure control of essential hypertension with bedtime dosing. Hermida RC; Ayala DE; Fontao MJ; Mojón A; Fernández JR Chronobiol Int; 2010 Jul; 27(6):1287-303. PubMed ID: 20653455 [TBL] [Abstract][Full Text] [Related]
16. Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: improved sleep-time blood pressure control with bedtime dosing. Hermida RC; Ayala DE; Mojón A; Fontao MJ; Fernández JR Chronobiol Int; 2011 Aug; 28(7):601-10. PubMed ID: 21823969 [TBL] [Abstract][Full Text] [Related]
17. Sleep-time blood pressure as a therapeutic target for cardiovascular risk reduction in type 2 diabetes. Hermida RC; Ayala DE; Mojón A; Fernández JR Am J Hypertens; 2012 Mar; 25(3):325-34. PubMed ID: 22158066 [TBL] [Abstract][Full Text] [Related]
18. Sleep-time ambulatory blood pressure as a prognostic marker of vascular and other risks and therapeutic target for prevention by hypertension chronotherapy: Rationale and design of the Hygia Project. Hermida RC Chronobiol Int; 2016; 33(7):906-36. PubMed ID: 27221952 [TBL] [Abstract][Full Text] [Related]